Donnenberg Lab

Dr. Vera Donnenberg’s research focuses on flow cytometry, broncho-alveolar lavage fluid, and analysis of dendritic cell subsets.  Dr. Donnenberg is investigating a new hypothesis that cancer originates from damaged tissue stem cells.

Currently, investigators are testing whether tumor stem cells from newly diagnosed previously untreated patients are uniquely resistant to common chemotheraputic agents, when the great majority of their tumor cells are susceptible. If this proves to be the case, this means that alternative therapies, such as tumor vaccines, must be directed against the drug-resistant tumor stem cell in order to effect a cure.

Division(s)

Research Type